In vitro effect of sulfamethoxazole-trimethoprim against Histoplasma capsulatum var. capsulatum

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 9, 2010, Pages 3978-3979

  Nogueira Brilhante, Raimunda Sâmia ^a   Bezerra Fechine, Maria Auxiliadora ^a   Cordeiro, Rossana De Aguiar ^a   Gadelha Rocha, Marcos Fábio ^a,b   Ribeiro, Joyce Fonteles ^a   Monteiro, André Jalles ^a   Chaves De Lima, Rita Amanda ^a   Lima Mesquita, Jacó Ricarte ^d   De Camargo, Zoilo Pires ^c   Costa Sidrim, José Júlio ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b STATE UNIVERSITY OF CEARÁ   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d Hospital São José   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; BROTH DILUTION; DRUG EFFECT; DRUG INHIBITION; FUNGAL STRAIN; FUNGUS ISOLATION; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCELIAL GROWTH; NONHUMAN; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; HISTOPLASMA; MICROBIAL SENSITIVITY TESTS; SULFAMETHOXAZOLE; TRIMETHOPRIM;

EID: 77956114153     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00793-10     Document Type: Article

References (14)

1. Afeltra, J., J. F. Meis, R. G. Vitale, J. W. Mouton, and P. E. Verweij. 2002. In vitro activities of pentamidine, pyrimethamine, trimethoprim, and sulfonamides against Aspergillus species. Antimicrob. Agents Chemother. 46:2029-2031.
2. Ajayi, B. G., B. Osuntokun, O. Olurin, O. O. Kale, and T. A. Junaida. 1986. Orbital histoplasmosis due to Histoplasma capsulatum var. duboisii: successful treatment with septrin. J. Trop. Med. Hyg. 89:179-187.
3. Baddley, J. W., I. R. Sankara, J. M. Rodriquez, P. G. Pappas, and W. J. Many, Jr. 2008. Histoplasmosis in HIV-infected patients in a southern regional medical center: poor prognosis in the era of highly active antiretroviral therapy. Diagn. Microbiol. Infect. Dis. 62:151-156.
4. Daher, E. F., G. B. Silva, Jr., F. A. Barros, C. F. Takeda, R. M. Mota, M. T. Ferreira, S. A. Oliveira, J. C. Martins, S. M. Araújo, and O. A. Gutiérrez-Adrianzén. 2007. Clinical and laboratory features of disseminated histoplasmosis in HIV patients from Brazil. Trop. Med. Int. Health 12:1108-1115.
5. Egere, J. U., H. C. Gugnani, A. N. Okoro, and A. V. Suseelan. 1978. African histoplasmosis in Eastern Nigeria: report of two culturally proven cases treated with septrin and amphotericin B. J. Trop. Med. Hyg. 81:225-229.
6. Ferreira, M. S., and A. S. Borges. 2009. Histoplasmose. Rev. Soc. Bras. Med. Trop. 42:192-198.
7. Fressatti, R., V. L. Dias-Siqueira, I. E. Svidzinski, F. Herrero, and C. Kemmelmeier. 1992. A medium for inducing conversion of Histoplasma capsulatum var. capsulatum into its yeast-like form. Mem. Inst. Oswaldo Cruz 87:53-58.
8. Hanafy, A., J. Uno, H. Mitani, Y. Kang, and Y. Mikami. 2007. In vitro antifungal activities of sulfa drugs against clinical isolates of Aspergillus and Cryptococcus species. Jpn. J. Med. Mycol. 48:47-50.
9. Kauffman, C. A. 2007. Histoplasmosis: a clinical and laboratory update. Clin. Microbiol. Rev. 20:115-132.
10. Li, R., M. A. Ciblak, N. Nordoff, L. Pasarell, D. W. Warnock, and M. R. McGinnis. 2000. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum. Antimicrob. Agents Chemother. 44:1734-1736.
11. Nakai, T., J. Uno, F. Ikeda, S. Tawara, K. Nishimura, and M. Miyaji. 2003. In vitro antifungal activity of micafungin (FK463) against dimorphic fungi: comparison of yeast-like and mycelial forms. Antimicrob. Agents Chemother. 47:1376-1381.
12. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. Document M27-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
13. Wheat, L. J., A. G. Freifeld, M. B. Kleiman, J. W. Baddley, D. S. McKinsey, J. E. Loyd, and C. A. Kauffman. 2007. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 45:807-825.
14. Yekutiel, A., I. Shalit, Y. Shadkchan, and N. Osherov. 2004. In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp. Antimicrob. Agents Chemother. 48:3279-3283. (Pubitemid 39129319)